Mesalamine to Reduce T Cell Activation in HIV Infection

NCT01090102 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
Sexually Transmitted Diseases
Immune System Diseases
Lentivirus Infections
Acquired Immunodeficiency Syndrome

Interventions

DRUG: Mesalamine (5-aminosalicylic acid, Apriso)
DRUG: Placebo

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]